Close

Analyst Ratings for NewAmsterdam Pharma Co NV (NAMS)

NAMS Rating Summary

NAMS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NAMS
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $33.25 (+73.3%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/15/2024 TD Cowen Tyler Van Buren New Coverage Buy
(N/A)
N/A
(N/A)
20.50
(19.19)
-6.39% Details
3/14/2024 Scotiabank George Farmer New Coverage Sector Outperform
(N/A)
35.00
(N/A)
23.43
(19.19)
-18.1% Details